antibiot therapi cystic fibrosi increas resist mucoid pseudomona aeruginosa carbenicillin present commun report effect bacteri mucu activ antibodi strain p aeruginosa mucoid variant p aeruginosa obtain nonmucoid strain pao 381 pat 404 select phenotyp resist virul phage e 79 resist carbenicillin nonmucoid parent strain mucoid p aeruginosa strain isol two cf patient resist carbenicillin nonmucoid strain isol sampl sputum experi alreadi describ repeat oxytetracyclin contrast experi carbenicillin mucoid strain found sensit nonmucoid strain prove hypothesi mucoid strain select vivo carbenicillin therapi necessari show level carbenicillin cf secret less minimum inhibitori concentr mucoid strain greater nonmucoid strain investig addit cf isol conjunct rang antibiot use chemotherapi cf patient